Nombre del producto:1-(2-fluorophenyl)ethanone

IUPAC Name:1-(2-fluorophenyl)ethan-1-one

CAS:445-27-2
Fórmula molecular:C8H7FO
Pureza:95%+
Número de catálogo:CM102461
Peso molecular:138.14

Unidad de embalaje Stock disponible Precio($) Cantidad
CM102461-500g in stock ȦǕ
CM102461-1000g in stock ɅƻƱ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :445-27-2
Fórmula molecular:C8H7FO
Punto de fusión:-
Código de sonrisas:CC(C1=CC=CC=C1F)=O
Densidad:1.137 g/mL at 20 °C(lit.)
Número de catálogo:CM102461
Peso molecular:138.14
Punto de ebullición:180.8°C at 760 mmHg
Nº Mdl:MFCD00000320
Almacenamiento:Store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Carbonyl Compounds
In organic chemistry, a carbonyl group is a functional group with the formula C=O, composed of a carbon atom double-bonded to an oxygen atom, and it is divalent at the C atom. It is common to several classes of organic compounds (such as aldehydes, ketones and carboxylic acids), as part of many larger functional groups. A compound containing a carbonyl group is often referred to as a carbonyl compound.
Vonoprazan
Nov. 01, 2023, FDA has approved VOQUEZNA (vonoprazan) tablets, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease).
PCABs are a novel class of medicines that block acid secretion in the stomach, and VOQUEZNA is the first PCAB to be approved in the U.S. Vonoprazan has shown the potential to provide acid suppression that can achieve pH levels that are important in enhancing treatment effectiveness.